UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000030810
Receipt No. R000035179
Scientific Title Regional survey of salt intake by presumptive salt intake-measurement with spot urine.
Date of disclosure of the study information 2018/01/15
Last modified on 2020/01/21 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Regional survey of salt intake by presumptive salt intake-measurement with spot urine.
Acronym Regional survey of salt intake with spot urine.
Scientific Title Regional survey of salt intake by presumptive salt intake-measurement with spot urine.
Scientific Title:Acronym Regional survey of salt intake with spot urine.
Region
Japan

Condition
Condition Healthy Adults
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Regional difference assessment of salt intake by presumptive salt intake-measurement with spot urine.
Basic objectives2 Others
Basic objectives -Others Regional survey
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Presumptive salt-intake (sodium, and creatinine)
Na/K ratio (sodium, and potassium)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
12 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Persons who give written informed consent, and have full ethical and regulatory approval
2. Healthy Japanese men and women over 20 years old, or aged 12~19 who got the consent of their guardians
Key exclusion criteria None
Target sample size 10000

Research contact person
Name of lead principal investigator
1st name Takuya
Middle name
Last name Tsuchihashi
Organization Steel Memorial Yawata Hospital
Division name President / hospital director
Zip code 805-0050
Address 1-1-1 Harunomachi, Yahatahigashi-ku, Kitakyushu City Fukuoka Pref., 805-8508, JAPAN
TEL 093-672-3140
Email tuti@ns.yawata-mhp.or.jp

Public contact
Name of contact person
1st name Takanori
Middle name
Last name Yasutake
Organization Healthcare Systems Co., Ltd.
Division name Marketing and Sales Promotion Division
Zip code 105-0004
Address Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, 105-0004, JAPAN
TEL 03-6809-2722
Homepage URL
Email yasutake@hc-sys.jp

Sponsor
Institute Steel Memorial Yawata Hospital
Institute
Department

Funding Source
Organization Healthcare Systems Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Shiga University of medical science.
Healthcare Systems Co., Ltd.
Name of secondary funder(s)

IRB Contact (For public release)
Organization STEEL MEMORIAL YAWATA HOSPITAL Ethical Review Board
Address 1-1-1 Harunomachi, Yahatahigashi-ku, Kitakyushu City Fukuoka Pref., 805-8508, JAPAN
Tel 093-672-3176
Email tanaka.ya@ns.yawata-mhp.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 10071
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 11 Month 20 Day
Date of IRB
2017 Year 11 Month 20 Day
Anticipated trial start date
2018 Year 01 Month 15 Day
Last follow-up date
2020 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Many of the survey of salt intake until now have used survey forms. In this trial, actual measurement of presumptive salt intake and Na/K ratio is carried out and an regional survey of salt intake by is conducted.

Management information
Registered date
2018 Year 01 Month 15 Day
Last modified on
2020 Year 01 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035179